Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic research
On Jul. 16, 2020, Codex DNA announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…
-
-
Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics
On Jul. 16, 2020, Tonix Pharmaceuticals announced it had entered into a research collaboration and option agreement with…
-
Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19
On Jul. 16, 2020, Atossa Therapeutics announced that it has contracted with Avance Clinical to conduct a clinical…
-
AXIM Biotechnologies unveiled first-in-class COVID-19 rapid diagnostic test for neutralizing antibodies
On Jul. 15, 2020, AXIM Biotechnologies announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of…
-
Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibility
On Jul. 15, 2020, A new Cleveland Clinic study identified genetic factors that may influence susceptibility to COVID-19….
-
Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2
On Jul. 15, 2020, Atossa Therapeutics announced successful results from in vitro testing of AT-301, Atossa’s proprietary COVID-19…
-
WHO and UNICEF warn of a decline in vaccinations during COVID-19
On Jul. 14, 2020, the WHO and UNICEF warned of an alarming decline in the number of children…
-
More than 150 countries engaged in COVID-19 vaccine global access facility
On Jul. 15, 2020, seventy-five countries submitted expressions of interest to protect their populations and those of other…
-
BIOFIRE respiratory panel 21 plus with SARS-CoV-2 was CE marked
On Jul. 15, 2020, bioMerieux announced that the BIOFIRE Respiratory Panel 2.1 plus (RP2.1plus) was CE marked. The…
-
COVID-19 antibody tests evaluated as diagnostic test in low-resource settings
On Jul. 15, 2020, scientists at Washington University School of Medicine in St. Louis reported they had joined…
-
BD announced purchase agreement with U.S. Dept of HHS to expand access to rapid point-of-care testing for COVID-19
On Jul. 15, 2020, BD (Becton, Dickinson) announced a commitment from the U.S. Department of Health and Human…
-
BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatment
On Jul. 15, 2020, BioAegis Therapeutics announced that it received regulatory clearance from The Spanish Agency for Medicines…
-
Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza
On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…
-
Philanthropic gifts funded COVID-19 pilot research projects at Einstein and Montefiore
On Jul. 15, 2020, four Einstein and Montefiore research teams received pilot funding from Einsteinﾒs Office of the…
-
CDC called on Americans to wear masks to prevent COVID-19 spread
On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…
-
HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2
On Jul. 14, 2020, researchers at the The University of Hong Kong (HKUMed) collaborated with researchers at the…
-
Fosun announced COVID-19 vaccine product received acceptance notice of clinical trial application by NMPA
On Jul. 14, 2020, Shanghai Fosun Pharmaceutical announced it had received the acceptance notice of clinical trial application…
-
Rigel announces investigator-sponsored trial of fostamatinib in patients with COVID-19 pneumonia
On Jul. 14, 2020, Rigel Pharmaceuticals announced the initiation of an investigator-sponsored tria being conducted by Imperial College…
-
Dynavax announced first participants dosed in phase 1 clinical evaluating Medicagoﾒs COVID-19 vaccine candidate
On Jul. 14, 2020, Dynavax Technologies announced that the first participants have been dosed in the Phase 1…
-
Moderna announced publication in The New England Journal of Medicine of interim results from phase 1 study of its mRNA vaccine against COVID-19
On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…
-
Pascal Biosciences discovered a cannabinoid that combats Coronavirus
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
-
Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19
On Jul. 14, 2020, Akebia Therapeutics announced the initiation of an investigator-sponsored study evaluating the use of vadadustat,…
-
Experimental COVID-19 vaccine safe, generated immune response
On Jul. 14, 2020, an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus…
-
CDC called on Americans to wear masks to prevent COVID-19 spread
On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…
-
Province of Alberta made 20 million masks available free of charge
On Jul. 13, 2020, 20 million masks were made available at more than 700 partner restaurant locations, including…
-
Engineered llama antibodies neutralised Covid-19 virus
On Jul. 13, 2020, a team of researchers from Oxford University, the Rosalind Franklin Institute, Diamond Light Source…
-
Phase II human trial of ViralClear’s anti-viral for SARS-CoV-2 Coronavirus launched at 4 key trial sites
On Jul. 13, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced the enrollment of adult patients for…
-
Innovation Pharma’s clinical trial testing of brilacidin against COVID-19 targeted to commence in 2020 fourth quarter
On Jul. 13, 2020, Innovation Pharma announced that, in parallel to previously reported manufacturing efforts, the Company had…
-
Altimmune and University of Alabama at Birmingham announced positive preclinical results for intranasal COVID-19 vaccine candidate, AdCOVIDﾙ
On Jul. 13, 2020, Altimmune announced positive results from the preclinical studies of its intranasal COVID-19 vaccine candidate,…
-
Bellerophon Therapeutics announced first patient treated in phase 3 clinical study of INOpulseﾮ inhaled nitric oxide therapy for COVID-19
On Jul. 13, 2020, Bellerophon Therapeutics announced that the first patient has initiated treatment in the Companyﾒs Phase…
